June 22 (Reuters) - The U.S. Food and Drug Administration said on Monday it is launching a series of measures to speed up ...
The agency says pairing drug sponsors with research institutions could cut development timelines by 6 to 12 months ...
The US Food and Drug Administration (FDA) is seeking comments on a pilot program where qualified external institutions will ...
The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
FDA revised guidance documents for low-risk wellness products and clinical decision software, clarifying regulatory ...
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
The FDA's new rules mean you can no longer just submit basic health data codes, since the most critical patient details are ...
Please provide your email address to receive an email when new articles are posted on . The FDA frequently identifies uncertainties about newly approved cancer drugs, but they are often omitted in ...
On June 18, 2026, the Food and Drug Administration (“FDA”) announced the submission of a proposed collection of information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results